of the data, which are largely from subjects of European ancestry. As a result, conclusions from these functional data may be limited when analyzing associated variants identified in the COGA-AA sample. Nonetheless, this represents an important first step towards characterizing genetic risk in a key index of AD liability. This study is also further strengthened by investigation of both EA and AA individuals, who are known to differ in SRE scores.
